top of page
< Back

Levetiracetam


Mechanism of action:

Levetiracetam is a pyrrolidone derivative. Levetiracetam binds with high affinity to synaptic vesicle protein 2A located at presynaptic nerve terminals, an important vesicle membrane protein involved in regulating neurotransmitter release. By modulating vesicle fusion and release processes, levetiracetam reduces excessive synchronized neuronal firing, especially under pathological hyperexcitable conditions, while having relatively little effect on normal neurotransmission. Through stabilization of neural network activity, it reduces neuronal hyperexcitability and abnormal discharges, thereby lowering the occurrence of epileptiform activity.

Reference(s):

1. Patsalos PN et al. (2004). Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet. 


2. Baltes S et al. (2007). Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology. 


3. Luna-Tortos C et al. (2008). Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology.

bottom of page